The ACR recently conducted a survey of U.S. members about the issue of drug safety, sources of information, and related issues. The survey netted 454 responses.
How to Win Over Information with Technology
Information overload—it’s the bane of my life. Some days I’m tempted to unplug all the fancy electronic gadgets that were designed to “keep us connected” and make our lives easier but instead often threaten to overwhelm us with the pressing need to respond immediately whenever our inbox flashes the arrival of yet another urgent message. For me, the challenge has become how to manage the inflow of data, messages, and information; stay current with the advances in my professional field; and carve out some quiet time free from beeping and flashing electronic reminders that relentlessly demand a response.
Help Patients with Scleroderma Manage Musculoskeletal and Functional Limitations
On March 10, Janet Poole, PhD, OTR, professor of the occupational therapy graduate program at the University of New Mexico in Albuquerque, will continue the ARHP’s Audioconference/Webcast Series with the management of scleroderma. Dr. Poole received her BS in occupational therapy from Colorado State University, her MA degree in educational psychology from the University of North Carolina, Chapel Hill, and her PhD in motor learning/motor control from the University of Pittsburgh. Dr. Poole’s research interest is in scleroderma and the functional impact of the disease on the tasks of daily living, oral hygiene, parenting, and employment. She has conducted a number of studies examining rehabilitation interventions with people who have scleroderma and, with a colleague, is developing a self-management program for these patients. She has also authored several textbook chapters on rehabilitation for people with scleroderma.
Healthcare in the Obama Administration
The ballots are counted, the run-off elections are complete, and a new administration and Congress are set to begin. You may recall that the mock election that was held during the 2008 Annual Scientific Meeting—78% of U.S. meeting attendees chose Barack Obama as their next president—and the general election echoed that choice. On January 20, Barack Obama was sworn in as the United States’ 44th President.
Fibromyalgia
Patient Fact Sheet
Coding Corner Question
February’s Coding Challenge
Coding Corner Answer
February’s Coding Answer
In America’s Recession, the REF Remains Strong
According to a survey conducted in October 2008 by the Washington Regional Association of Grantmakers, three-quarters of the region’s leading foundations and corporate giving programs suffered a decline in assets because of plummeting returns on investments over 2008. About one-third of the respondents said they reduced grant budgets from 2007 to 2008, and about half of the organizations said they plan to award fewer grants in 2009.
State-of-the-Art Clinical Symposium: New Offerings, Returning Favorites
If you are looking for a CME symposium that will present up-to-date, cutting-edge information on a broad array of topics in rheumatology in an intimate setting, you won’t want to miss the 2009 ACR State-of-the-Art Clinical Symposium held Friday, April 17–Sunday, April 18 in Chicago, Ill.
Electronic Prescribing: The First Step Towards an Integrated Health Delivery System?
With the introduction of the 2009 Centers for Medicare and Medicaid Services’ (CMS’s) electronic prescribing incentive program, the door is opening for widespread adoption of health information technology (HIT) within the physician’s practice.
Office Visit
A day in the life of John Schousboe, MD, PhD
Take Our Regulators—Please!
May 2009 bring us a return to constructive, thoughtful oversight in all fields
Fresh Chances for Advocates
Will a new year and a new president bring new advances in healthcare reform?
Get Info, Get Moving
Practical, evidence-based tips to prevent falls in patients with arthritis
Designed for Translation
Tips to move research into practice through researcher–implementer dialogue
Know Your Labs
A review of state-of-the-art testing for SLE and connective tissue disease.